Synergy Pharmaceuticals Inc fka SGYPQ

[420man]

Once the back and forth of issues of SGYP selling to Bausch is over and finalized, SGYP will very likely exit BK as pretty much a shell (in regards to traders/investors interest). After delisting, and the Q possibly removed in the coming months, they will then (If they still exist), most certainly have to seek institutional funding. Very interesting how this has, and is unfolding, along with how the stock has traded over the past few months!